Results 1 to 10 of about 62,245 (203)

Lebrikizumab for adolescent atopic dermatitis: 24-week real-world outcomes from the Czech BIOREP registry. [PDF]

open access: yesJAAD Int
Rob F   +7 more
europepmc   +1 more source

Clinical profile of ocular allergy and its impact on quality of life in Brazilian children and adolescents. [PDF]

open access: yesRev Paul Pediatr
Marino LM   +6 more
europepmc   +1 more source

Case Series: Combination of dupilumab and omalizumab as a way to reduce dupilumab-associated adverse events in severe atopic dermatitis. [PDF]

open access: yesFront Allergy
Fomina DS   +7 more
europepmc   +1 more source

Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary Centre. [PDF]

open access: yesDermatol Ther (Heidelb)
Abraheem A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy